Ilyang Pharmaceutical KRX:007570KOSPI
일양약품 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days9
DART filings, 7 days4
Articles tracked9since Sep 11
In Q2 2026, Ilyang Pharmaceutical reported revenue of ₩65.1bn, up 3.9% year on year, and an operating loss of ₩6.8bn. Ilyang Pharmaceutical (일양약품) appeared in 9 Korean news articles and 4 DART filings over the past seven days. Coverage peaked on Sep 11 with 9 articles. The most common catalyst was contracts & orders (1).
Ilyang Pharmaceutical quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩65.1bn | +3.9% | −₩6.8bn | −₩2.3bn |
| Q1 2026 | ₩65.1bn | +5.0% | −₩7.4bn | ₩17.0bn |
| Q4 2025 derived | ₩78.9bn | +825.7% | ₩566m | −₩5.6bn |
| Q3 2025 | ₩68.8bn | -30.6% | −₩158m | ₩8.4bn |
| Q2 2025 | ₩62.7bn | +7.2% | ₩1.2bn | ₩613m |
| Q1 2025 | ₩62.0bn | +5.5% | ₩3.4bn | ₩3.8bn |
| Q4 2024 derived | ₩8.5bn | +2284.0% | −₩43m | ₩2.2bn |
| Q3 2024 | ₩99.1bn | -1.5% | ₩5.5bn | ₩3.8bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Ilyang Pharmaceutical top stories 2 weeks, by number of outlets
- 1
- 2
Latest Ilyang Pharmaceutical news Korean headlines
-
[부음] 일양약품, 前홍보실장 유방희 이사 본인상
7 more on this story · 7 outlets
- 일양약품, 前 홍보실장 유방희 이사 본인상약사공론 · Sep 11 14:37
- [부음] 일양약품 전(前) 홍보실장 유방희 이사팜뉴스 · Sep 11 14:37
- [부음]일양약품 전 홍보실장 유방희 이사 본인상PRESS9 · Sep 11 14:43
- [부음] 일양약품 유방희 전 홍보실장 본인상청년의사 · Sep 11 15:00
- 일양약품, 前홍보실장 유방희 이사 本人喪보건신문 · Sep 11 15:10
- 일양약품 전 홍보실장 유방희 이사 본인상메디파나뉴스 · Sep 11 16:49
- (부음)유방희 전 일양약품 홍보실장 본인의약뉴스 · Sep 11 17:57